Código QR (código de barras bidimensional)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

ver descrição completa

Na minha lista:
Principais autores: Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrinology Research Centre 2017-12-01
coleção:Сахарный диабет
Assuntos:
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
farnesoid x
Acesso em linha:https://www.dia-endojournals.ru/jour/article/view/9374
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados